including ATF6, IRE1, and PERK. HCV increases TGF-β1 and oxidative stress, which play important roles in liver fibrogenesis. HCV has been shown to induce TGF-β1 through the generation of reactive oxygen species (ROS) and p38 MAPK, JNK, ERK1/2, and NFκB-dependent pathways. However, the relationship between HCV-induced ER stress and UPR activation with TGF-β1 production has not been fully characterized. In this study, we found that ROS and JNK inhibitors block HCV up-regulation of ER stress and UPR activation. ROS, JNK and IRE1 inhibitors blocked HCV-activated NFκB and TGF-β1 expression. ROS, ER stress, NFκB, and TGF-β1 signaling were blocked by JNK specific siRNA. Knockdown IRE1 inhibited JFH1-activated NFκB and TGF-β1 activity. Knockdown of JNK and IRE1 blunted JFH1 HCV upregulation of NFκB and TGF-β1 activation. We conclude that HCV activates NFκB and TGF-β1 through ROS production and induction of JNK and the IRE1 pathway. HCV infection induces ER stress and the UPR in a JNK-dependent manner. ER stress and UPR activation partially contribute to HCV-induced NF-κB activation and enhancement of TGF-β1.
its spliced form (XBP-1s). The XBP-1s protein functions as a transcriptional activator of UPR genes that contain the unfolded protein responsive elements (UPREs) and ER-associated degradation (ERAD)-related genes 14 . PERK is an ER-resident transmembrane protein and is activated in a similar manner as IRE1 15 . The activated PERK subsequently phosphorylates eukaryotic translation initiation factor 2α (eIF2α ) and leads to inhibition of translation initiation 16 . Transforming growth factor β (TGF-β 1) plays a major pathophysiological role in fibrogenesis and growth dysregulation in cancerous and apoptotic cells 17 . Patients with chronic HCV infection have higher levels of TGF-β 1, both total and biologically active forms, compared with healthy controls. Immunohistochemical staining of liver sections revealed that 62% of HCV patients have TGF-β 1 present in sinusoidal cells of liver tissue 18 . Elevated serum levels of TGF-β 1 have been found in chronic HCV-infected patients, as compared to healthy controls 19 . In addition, HCV core induced TGF-β 1 transcription upregulation has been shown in cell lines 20 . HCV JFH-1 infection in Huh-7 cells induces transcriptional stimulation, synthesis, and secretion of bioactive TGF-β 1 in a time-dependent manner 21 . We have previously demonstrated that the JFH-1 cell culture infectious HCV induces TGF-β 1 through the generation of reactive oxygen species (ROS) and p38 MAPK, JNK, ERK1/2, NFκ B-dependent pathways 2, 22, 23 . However, the mechanism by which HCV-induced ER stress, UPR activation, and TGF-β 1 production are linked has not been fully characterized. We therefore sought to determine whether HCV induces TGF-β 1 production through ER stress and UPR activation pathways using the infectious JFH1 HCV replication model. We hypothesized that HCV induction of TGF-β 1 is mediated by ER stress and the UPR.
Results
HCV infection induces the antioxidant response, ER stress, NFκB, and TGF-β1 gene expression. The induction of ROS, ER stress, NFκ B, and TGF-β 1 in JFH1 HCV-infected Huh7.5.1 cells was examined and compared to uninfected cells. Cells were infected with JFH1-HCV and viral replication was assessed The pRL-TK expressing Renilla luciferase was co-transfected as an internal control. ER stress pathway was monitored by a dual luciferase reporter assay system at 24 hours after transfection. HCV infection increased Nrf2/1, ERSE, NFκ B, and SMAD luciferase signaling by 6.7, 8.4, 2.8, and 4.7-fold, respectively compared with un-infected Huh 7.5.1 cells (Fig. 1A-D) . Relative luciferase activity (RLA) was normalized by dividing the firefly luciferase value by the Renilla luciferase value. *p < 0.05; and **p < 0.01 compared with un-infected Huh7. by qRT-PCR. We studied whether HCV infection induced ROS, ER stress, NFκ B, and TGF-β 1 signaling. We measured the effects of JFH1-HCV on Nrf2/1, ERSE, NFκ B, and TGF-β 1-mediated transcriptional activity using a luciferase reporter construct containing the corresponding functional binding site. HCV infection increased pARE luciferase signaling in HCV-infected Huh7.5.1 cells by 6.7-fold compared with un-infected Huh7.5.1 cells at day 3 of infection (p = 0.007; Fig. 1A ). The pARE reporter was designed to measure the transcriptional activity of the Nrf2 and Nrf1 transcription factors. Nrf2 and Nrf1 act as sensors for oxidative stress and direct transcription from the antioxidant response element (ARE). HCV increased pERSE-luciferase signaling in JFH1 cells by 8.4-fold compared with Huh7.5.1 cells at day 3 of infection (p = 0.003; Fig. 1B) . The ERSE reporter monitored activity of the endoplasmic reticulum (ER) stress pathway. HCV infection increased NFκ B signaling in JFH1 cells by 2.8-fold compared with Huh7.5.1 cells (p = 0.022; Fig. 1C ). The NFκ B-responsive luciferase construct encodes the firefly luciferase reporter gene under the control of a CMV promoter and tandem repeats of the NFκ B transcriptional response element (TRE). HCV infection increased pSMAD luciferase signaling in HCV-infected Huh7.5.1 cells by 4.7-fold compared with un-infected Huh7.5.1 cells (p = 0.013; Fig. 1D ). The SMAD reporter construct was designed to monitor the activity of TGF-β -induced signal transduction pathways. TGF-β signaling induces phosphorylation and activation of the SMAD2 and SMAD3 proteins, which then form complexes with SMAD4 and translocate to activate the expression of TGFβ -responsive genes.
HCV infection activated each of the three arms of the UPR. We next examined the induction of the UPR in uninfected or JFH1 HCV-infected Huh7.5.1 cells over a 7-day time course. Each of the three arms of the UPR was activated in a wave-like pattern. We found that JFH1-HCV infection increased levels of the cleaved active form of ATF6 that peaked at day 3. The IRE1 pathway was also induced in JFH1-infected cells. Phosphorylated PERK was also detected in Huh7.5.1 cells infected with JFH1 ( Fig. 2A) . The level of spliced Fig. 2A) . Gene expression levels of spliced XBP-1, ATF3, and ATF4 at day 1, 3, 5, and 7 of infection were determined by real-time PCR and normalized to GAPDH. We found that the spliced XBP-1 mRNA level in JFH1-infected Huh7.5.1 cells increased by 2.7-fold at day 3 post infection compared to uninfected Huh7.5.1 cells (Fig. 2B) . The spliced ATF3, and ATF4 mRNA levels were elevated by 20.5, 5.8-fold, respectively, in JFH1-infected Huh7.5.1 cells at day 3 post-infection compared to uninfected Huh7.5.1 cells (Fig. 2C,D ). *p < 0.05; **p < 0.01; and #p < 0.001 compared between JFH1-infected and un-infected Huh7. XBP-1s mRNA was significantly elevated at day 3 compared to uninfected cells (Fig. 2B) . Similarly, mRNA levels of ATF3 and ATF4 were up-regulated by 20.5 and 5.8 fold, respectively, at the same time point compared to uninfected cells (Fig. 2C,D) (p = 0.001, 0.008). These data indicate that HCV induces each of the three arms of the UPR, including ATF6, IRE1α , and PERK.
ROS and JNK inhibitors block HCV up-regulation of ER stress and UPR activation. To determine how HCV induces the ER stress and UPR pathways, we assessed the activity of ARE and ERSE reporters in un-infected or JFH1-infected cells treated with several different pathway inhibitors. DPI, a blocker of ROS formation, decreased HCV-induced ARE and ERSE signaling, compared with JFH1-infected Huh7.5.1 cells (Fig. 3A ,B, p = 0.014, and 0.018, respectively). The JNK inhibitor SP also blocked ERSE signaling in JFH1-infected Huh7.5.1 cells (Fig. 3B , p = 0.005). None of the tested inhibitors had an effect on cell viability (Fig. 3C) . Additionally, HCV-induced XBP1s, ATF3 and ATF4 mRNA expression were reduced by DPI and SP (Fig. 4A-C, respectively) . At the protein level, the ROS inhibitor DPI decreased the HCV-induced phosphorylation of p38MAPK, JNK, ERK, IRE1, PERK and the cleaved form of ATF6. Furthermore, the JNK inhibitor SP blocked HCV-induced IRE1, PERK phosphorylation and ATF6 cleavage (Fig. 4D ). These data indicate that HCV promotes ROS generation and subsequently activates ER stress through the JNK pathway. We also found that IREstatin reduced HCV-induced XBP-1 (p = 0.047), and GSK inhibited HCV-induced ATF3 and ATF4 mRNA (p = 0.044, and 0.045, respectively) enhancement. These findings suggest that IRE1 is in the upstream of XBP-1 and PERK is upstream of ATF3 and ATF4.
ROS, JNK and IRE1 inhibitors block HCV-activated NFκB and TGF-β1.
The effects of several different pathway inhibitors on NFκ B and TGFβ -mediated transcriptional activity were measured using a luciferase reporter construct in JFH1-HCV-infected and uninfected Huh7.5.1 cells. We found that ROS inhibitor DPI and the NFκ B inhibitor AQ each completely blocked HCV-induced NFκ B and TGF-β 1 induced-SMAD signaling ( The pRL-TK expression Renilla luciferase was co-transfected as an internal control. After 24 hours of transfection, cells were treated with several pathway inhibitor including DPI, SB, SP, U0126, LY, AEBSF, IREstatin, and GSK at 20 μM each. 1% DMSO was used as a negative control. ARE-mediated Nrf2 and ER stress signaling pathway were monitored by dual luciferase reporter assay at 24 hours after inhibitor treatment. Relative luciferase activity (RLA) was normalized by dividing the firefly luciferase value by the Renilla luciferase value. DPI (ROS inhibitor) decreased HCV-induced ARE signaling in JFH1-infected Huh7.5.1 cells. DPI and SP (JNK inhibitor) blocked HCV-induced ERSE signaling in JFH1-infected cells (Fig. 3A,B ). There was no significant difference in proliferation between untreated and inhibitor treated cells at 6, 12, 24, and 48 hours of the treatment (Fig. 3C ). **p < 0.01 for comparison of indicated treatment to the JFH1-infected cells in DMSO.
and partially reduced HCV-induced TGF-β signals (p = 0.043, 0.031, 0.033 and 0.025, respectively). Furthermore, HCV-induced TGF-β 1 mRNA expression enhancement was completely blocked by DPI or AQ, and partially inhibited by SP, SB, U0126 and IREstatin (Fig. 5C , p = 0.006, 0.044, 0.020). Additionally, immunoblotting showed that DPI and AQ each completely blocked HCV-induced NFκ B phosphorylation, SP, SB, U0126, and IREstatin partially decreased JFH1-induced NFκ B phosphorylation (Fig. 5D ). Taken together, our data suggest that IRE1 plays a partial role in the induction of NFκ B and TGF-β 1 during HCV infection. These data show that HCV activates NFκ B and TGF-β 1 through ROS production and partial through induction of JNK and the IRE1 pathway.
siRNA-mediated knockdown of JNK and IRE1 inhibited JFH1 HCV activated ER stress, NFκB, and TGF-β1 luciferase activity. Based on our data above, we sought to further assess whether IRE1 was responsible for the induction of NFκ B and TGF-β 1 in HCV infection. To accomplish this, luciferase reporter experiments were performed to analyze levels of Nrf2/1, ERSE, NFκ B, and TGF-β 1-mediated transcriptional activity after siRNA-mediated knockdown of JNK, IRE1, ATF6, and PERK in Huh7.5.1 cells either mock-infected or infected with HCV. To confirm that HCV induces NFκ B and TGF-β 1 expression through a ROS production-JNK-IRE1 pathway, the ROS, ER stress, NFκ B, and TGF-β 1 promoter-driven luciferase activity were monitored in JFH1-infected cells transfected with siRNA-mediated knockdown of JNK, IRE1, ATF6, and PERK. We found that ON-TARGET plus SMART pool human siRNAs exhibited stronger mRNA knockdown effects compared to individual siRNA species (Fig. 6A-D) . We found that ARE signaling was not affected by siRNA against JNK, IRE1, ATF6, and PERK (Fig. 7A) . ERSE signaling was completely blocked by siRNA against Figure 4 . ROS and JNK inhibition decreased HCV-induced ER stress and UPR activation. Huh7.5.1 cells and Huh7.5.1 infected with JFH1 for 3 days were treated with several pathway inhibitor including DPI, SB, SP, U0126, LY, AEBSF, IREstatin, and GSK at the concentration 20 μM for 24 hours. 1% DMSO was used as a negative control. Gene expression levels of spliced XBP-1, ATF3, and ATF4 were determined by real-time PCR and normalized to GAPDH. We found that HCV-induced XBP-1s mRNA expression enhancement reduced by DPI, SP, and IREstatin treatments in JFH1-infected Huh7.5.1 cells compared with DMSO control. HCVinduced ATF3 and ATF4 mRNA expression enhancement was inhibited by DPI, SP, and GSK treatments, compared with DMSO control (Fig. 4A-C ). *p < 0.05 for comparison of indicated treatment to the JFH1-infected cells in DMSO. Whole cell lysates were analyzed by western blot to measure phospho-JNK, phospho-IRE1, phospho-PERK, cleaved-ATF6, phospho-p38MAPK, and phospho-ERK. DPI decreased the HCVinduced phosphorylation of JNK, IRE1, PERK, p38MARK, ERK and the cleaved form of ATF6. SP blocked HCV-induced IRE1, PERK phosphorylation and ATF cleavage (Fig. 4D) . We added 20 μg of protein to each well to assure equal protein loading in each lane. JNK (Fig. 7B, p = 0.022) . NFκ B and TGF-β 1 luciferase signaling were partially blocked by JNK and IRE1 specific siRNAs (Fig. 7C , p = 0.026, and 0.038, respectively; Fig. 7D , p = 0.032, and 0.025, respectively). In contrast, the ROS, NFκ B, and TGF-β 1 responsive reporters were not blocked by ATF6 and PERK-specific knockdown (Fig. 7A-D) , indicating that ATF6 and PERK are independent of TGF-β 1 induction.
siRNA-mediated knockdown of JNK and IRE1 blocks HCV up-regulation of NFκB and TGF-β1 activation. RNA interference experiments were performed to assess the effects of JNK, IRE1, ATF6, and PERK knockdown on XBP1s, ATF3, ATF4, and TGF-β 1 mRNA levels. As expected, JNK and IRE1 silencing partially decreased HCV-induced TGF-β 1 (Fig. 8A , p = 0.039, and 0.035, respectively), and JNK siRNA blocked HCV-induced XBP1s, ATF3, and ATF4 mRNA expression enhancement in JFH1-infected cells (Fig. 8B-D) . We found that IRE1 specific siRNA completely inhibited XBP1s mRNA expression but had no effect on ATF3 and ATF4 mRNA expressions. PERK specific siRNA did not affect TGF-β 1 and XBP-1 mRNA levels (Fig. 8A,B) , but reduced ATF3 and ATF4 mRNA expression, suggesting that PERK is upstream of ATF3 and ATF4. In contrast, ATF6 and PERK siRNAs did not affect TGF-β 1, XBP1s, mRNA expression, indication that ATF6 and PERK are independent of the TGFB1 and ER stress pathways. We further examined the phosphorylation state of JNK1, IRE1, PERK, NFκ B, and ATF6 activation in HCV-infected JNK, IRE1, ATF6, and PERK knockdown Huh7.5.1 cells. As expected, immunoblotting showed that JNK siRNA decreased JFH1-induced IRE1 phosphorylation, PERK phosphorylation, ATF6 activation, and NFκ B phosphorylation. We found that each of the testes siRNAs did not affect cell viability (Fig. 9B) . Additionally, IRE1 knockdown decreased NFκ B phosphorylation. The siRNA-mediated knockdown of ATF6 and PERK did not affect NFκ B activation (Fig. 9A) . Taken together, Figure 5 . ROS, JNK, and IRE1 inhibitor decreased HCV activated NFκB and TGF-β1. Huh7.5.1 cells and Huh7.5.1 infected with JFH1 for 3 days were transfected with plasmid pNFκ B or pSMAD-luciferase reporter for 24 hours. The pRL-TK expression Renilla luciferase was co-transfected as an internal control. After the transfection, cells were treated with several pathway inhibitor including DPI, SB, SP, U0126, LY, AQ, AEBSF, IREstatin and GSK (20 μM). 1% DMSO was used as a negative control. Luciferase signaling was monitored by a dual luciferase reporter assay at 24 hour after inhibitor treatment. Relative luciferase activity (RLA) was normalized by dividing the firefly luciferase value by the Renilla luciferase value. DPI, SB, SP, U0126, AQ, or IREstatin treatment decreased HCV-induced NFκ B and TGF-β 1 promoter signaling compared with DMSO control in JFH1 cells (Fig. 5A,B) . TGF-β 1 mRNA level was determined by real-time PCR and normalized to GAPDH. We found that HCV-induced TGF-β 1 mRNA expression enhancement was blunted by DPI, SP, SB, U0126, AQ or IREstatin treatment compared with DMSO control in JFH1 cells (Fig. 5C ). Whole cell lysates were analyzed by western blot to detect NFκ B phosphorylation. DPI, SP, SB, U0126, AQ and IREstatin decreased HCV induced NFκ B phosphorylation in JFH1 cells (Fig. 5D) . these findings indicate that HCV induces NFκ B and TGF-β 1 through a ROS production-JNK-IRE1 dependent pathway.
Discussion
HCV replication induces the formation of a membrane associated replication complex. Its replication activates ER stress and induces the UPR. HCV uses ER stress and manipulates the cellular response to ER stress to promote its persistence and pathogenesis. HCV-induced cellular responses may contribute to chronic liver disease by modulating cell proliferation, altering lipid metabolism, and potential oncogenic pathways. NFκ B activation is triggered by oxidative stress and ER stress in cells that support HCV replication 24 . Our previous work has demonstrated that HCV induces ROS and TGF-β 1 expression. HCV-mediated TGF-β 1 enhancement occurs through a ROS-induced and p38 MAPK, JNK, ERK1/2, NFκ B-dependent pathway 22, 23 . TGF-β 1 expression has been implicated in the pathogenesis of liver fibrosis 25 . However, whether and how HCV-induced ER stress, UPR activation, and TGF-β 1 production are linked has not been established. The objective of our study was to determine whether HCV induces TGF-β 1 production through ER stress and UPR activation pathways using the cell culture infectious JFH1 HCV model.
In this study, we discovered that HCV induces ER stress and activates all three arms of the UPR through c-Jun N-terminal kinase (JNK). Additionally, we found that during HCV infection, the IRE1-XBP1 pathway is activated, as demonstrated by the presence of spliced XBP1 mRNA. We found that knockdown of JNK and IRE1-JFH1 cells decreased the expression of NFκ B and TGFβ 1. Given that the activation of the IRE1-XBP1 pathway correlates with expression of NFκ B and TGF-β 1 in JFH1-HCV-infected cells, it therefore appears plausible that signaling through this pathway is important during HCV infection and implicates its involvement in HCV pathogenesis. To this end, it has been shown that UPR induced by HCV positively regulates HCV RNA replication in a cell culture system supporting efficient HCV propagation as abrogation of one of the three known UPR pathways suppresses HCV replication 26 . It is possible that the UPR induced by HCV perpetuates viral infection by relieving cells from stress conditions and facilitating replication. Additionally, we found that ER stress partially contributes to HCV-induced NF-κ B activation and enhancement of TGF-β 1 expression via the IRE1 arm of the UPR. HCV infection has been linked to ER stress, which is associated with ROS production in patients with chronic infection 27 . Reactive oxygen species can induce the proliferation of hepatic stellate cells (HSCs) and release of TGF-β 1. Multiple studies have reported that ROS mediates activation of the p38 MAPK, JNK, ERK, and NFκ B pathways 22 . Our study provides new evidence, using an infectious tissue culture model, that HCV induces ER stress and the UPR in a JNK-dependent manner. ER stress and UPR activation partially contribute to HCV-induced NFκ B activation and enhancement of TGF-β 1 expression.
We therefore propose a model in which HCV induces ROS induction, which in turn activates the phosphorylation of JNK. Phosphorylated JNK subsequently induces ER stress. The activation of one arm of the UPR pathway, IRE1, in turn induces the phosphorylation of NFκ B. The activated NFκ B translocates to nucleus and up-regulates TGF-β 1 expression (Fig. 10) . This study provides insight into the intracellular signaling events in HCV infected cells and extends our knowledge regarding the mechanisms of ER stress, the UPR-pathway and TGF-β 1 activation. Our results further suggest that strategies to counteract HCV-associated liver pathogenesis could be directed against key intracellular events (ER stress and oxidative stress) induced by HCV.
Methods
Cell Culture. The human hepatocellular carcinoma cell line, Huh 7.5.1, was obtained from Dr. Frank Chisari, Scripps Institute, CA. Huh 7.5.1 cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum and 100 units of penicillin/ml.
HCV infection.
Cell supernatant containing the infectious JFH1 HCV virus was used to infect naïve Huh 7.5.1 cells at appropriate dilutions (moi = 0.2) for luciferase reporter assays and RNA interference studies as previous descriptions [28] [29] [30] .
Reagents/Inhibitors. To study the impact of HCV infection on ER stress, NFκ B, and TGF-β 1 induction, inhibitors of intermediate steps were tested, including inhibitors of ROS (diphenyliodonium; DPI), p38 MAP kinase (SB203580; SB), JNK (SP600125; SP), ERK1/2 (U0126), PI3K (LY294002; LY), NFκ B activation (6-amino-4-(4-phenoxyphenylethylamino; AQ), ATF6 (AEBSF), PERK (GSK2606414; GSK). These compounds were obtained from Calbiochem, San Diego, CA. The IRE1 inhibitor Irestatin 9389 was obtained from Figure 7 . siRNA-mediated knockdown of JNK and IRE1 inhibited JFH1 HCV-activated ER stress, NFκB and TGF-β1 luciferase activity. Huh7.5.1 cells and Huh7.5.1 infected with JFH1 for 3 days were transfected with 25 nM small interfering RNA (siRNA) against JNK, IRE1, ATF6 or PERK. After 48 hours of transfection, cells were transfected with pARE, pERSE, pNFκ B or pSMAD-luciferase reporter. ARE-mediated Nrf2, ERSE, pNFκ B or pSMAD signaling were monitored by a dual luciferase reporter assay system at 24 hours after luciferase reporter transfection. We found that ARE-mediated Nrf2 signaling was not blocked by JNK, IRE1, ATF6 or PERK-specific knockdown (Fig. 7A) . ERSE luciferase signaling was blocked by JNK siRNA (Fig. 7B) . The siRNA-mediated knockdown JNK and IRE1 inhibited HCV-activated NFκ B and SMAD luciferase activity in JFH1 cells compared to uninfected Huh7.5.1 cells (Fig. 7C,D ). *p < 0.05 for comparison of indicated siRNAmediated knockdown and JFH1-infected cells.
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AxonMedchem, Netherlands. The inhibitors stock solution was dissolved in 1% dimethyl sulfoxide (DMSO) and 1% used as a negative control. The cells were incubated with appropriate inhibitors at a final concentration of 20 μM for 24 hours.
Luciferase Reporter Assays. Uninfected and HCV-infected Huh 7.5.1 cells were transfected with Cignal Antioxidant Response, ERSE, and SMAD Response Luciferase Reporters (SABiosciences, Frederick, MD) by using Fugene HD transfection reagent (Roche, Indianapolis, IN) according to the manufacturer's protocol. NFκ B signaling was quantified using an NFκ B promoter construct expressing firefly luciferase (pNFκ B-Luc) and a construct expressing Renilla luciferase (pRL-TK) as an internal background control. The ARE reporter was designed to measure the transcriptional activity of the Nrf2 and Nrf1 transcription factors. Nrf2 and Nrf1 act as sensors for oxidative stress and direct transcription from the antioxidant response element (ARE). The ERSE reporter construct monitored activity of the endoplasmic reticulum (ER) stress pathway. The ERSE is a motif that mediates the transcriptional response to ER stress. The NFκ B reporter construct was designed to monitor the activity of NFκ B-regulated signal transcription pathways. The NFκ B-responsive luciferase construct encodes the firefly luciferase reporter gene under the control of a CMV promoter and tandem repeats of the NFκ B transcriptional response element (TRE). The SMAD reporter construct was designed to monitor the activity of TGF-β -induced signal transduction pathways. TGF-β signaling induces phosphorylation and activation of the SMAD2 and SMAD3 proteins, which then form complexes with SMAD4 and translocate to activate the expression of TGFβ -responsive genes. Cells were harvested and cellular lysates were analyzed for luciferase reporter assay kit (Promega, Madison, WI). Relative luciferase activity (RLA) was normalized by dividing the firefly luciferase value by the Renilla luciferase value. , and ATF4 were determined by real-time PCR and normalized to GAPDH. We found that JNK siRNA or IRE1 siRNA blunted HCV-induced TGF-β 1 and XBP-1s mRNA enhancement in JFH1-infected Huh7.5.1 cells (Fig. 8A,B) . JNK siRNA or PERK siRNA decreased HCV-induced ATF3 and ATF4 mRNA expression enhancement in JFH1-infected Huh7.5.1 cells (Fig. 8C,D ). *p < 0.05 for comparison of indicated siRNA-mediated knockdown and JFH1-infected cells.
Scientific RepoRts | 6:22487 | DOI: 10.1038/srep22487 performed according to the manufacturer's instructions. Seventy-two hours after transfection knock-down efficiency was assessed by real-time PCR and Western blotting from lysate of siRNA-transfected cells.
Analysis of Gene Expression by Quantitative Real-time PCR.
Total cellular RNA was isolated using the QIA Shredder and RNeasy kit (Qiagen, Valencia, CA), as described by the manufacturer's protocol. Reverse transcription was performed using Applied Biosystems high-capacity cDNA reverse transcription kits (Invitrogen, Carlsbad, CA) with random primers. To quantify gene expression, quantitative real-time PCR was performed in the Bio-Rad IQ5 system (Bio-Rad Laboratories, Hercules, CA) using Finnzymes SYBR green I dye (New England Biolabs, Ipswich, MA), and sequence-specific primers, as indicated in Table 1 . The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was used as an internal control. The reactions were performed under the following conditions: 95 °C for 3 min, followed by 45 cycles at 94 °C for 20 seconds, 60 °C for 31, 32 . Cell lysates were sonicated and cleared by centrifugation at 14,000 rpm for 15 min at 4 °C. Protein concentration was determined and samples were boiled at 95 °C for 5 min in SDS-PAGE sample buffer. Twenty micrograms of protein were loaded into each well and were separated on a NuPAGE Novex precast 4-to-12% gradient Bis-Tris gels (Invitrogen, Carlsbad, CA) using the SDS-PAGE technique. The proteins were transferred to nitrocellulose membranes and blocked with 5% bovine serum albumin (BSA) in TBS/Tween. The blotted membranes were probed overnight at 4 °C with specific primary antibodies. The secondary antibodies used were horseradish peroxidase (HRP)-conjugated ECL donkey anti-rabbit IgG and HRP-conjugated ECL sheep anti-mouse IgG (Amersham Biosciences, Piscataway, NJ). Chemiluminescence detection of the bands was performed using the ECL Western blotting detection kit (Amersham Biosciences, Piscataway, NJ). Membranes were probed with anti-actin (Sigma-Aldrich, St. Louis, MO) to confirm equal loading.
Cell proliferation assay. Cell proliferation was analyzed by using the Cell Counting Assay Kit-8 (CCK-8) (Dojindo Molecular Technologies, Gaithersburg, MD) according to the manufacturer's protocol. At 6, 12, 24, or 48 hours post inhibitor treatment or transfection, the cells were washed with PBS. Ten microliters of CCK-8 solution was added to each well, the cells were incubated for 1 hour, and the absorbance at 490 nm was measured using the automatic multiwall spectrophotometer (Bio-Rad, Richmond, CA). Experiments were performed in triplicate with representative data presented.
Antibodies.
Each of the primary antibodies were used according to the manufacturer's protocol:
Phospho-JNK #4671, JNK #9252, IRE1α #3294, PERK #5683, phospho-p38 MAPK #9215, p38 MAPK #9212, phospho-p44/42 MAPK #9106, p44/42 MAPK #4695, (Cell Signaling, Danvers, MA). phospho-IRE1α #PA1-16927, phospho-PERK #MA5-15033, and HCV core (Thermo Scientific, Rockford, IL). ATF6 #ab11909 (Abcam, Cambridge, MA).
Statistical Analysis. Statistical analysis was conducted using the 2-tailed Student t test. Data are expressed as means ± standard deviations (S.D.). Triplicate determinations were performed in all real-time experiments, and all experiments were repeated at least three times. 
